Literature DB >> 21157458

20-HETE in acute kidney injury.

Richard J Roman1, Talha Akbulut, Frank Park, Kevin R Regner.   

Abstract

Ischemia/reperfusion injury (IRI) is a common cause of acute kidney injury (AKI) that is associated with a patient mortality of up to 50%. Currently there are not effective pharmacologic therapies for AKI. This Commentary highlights recent evidence indicating that 20-HETE plays an important role in IRI and that drugs that target this pathway have potential as therapeutic agents for AKI.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21157458      PMCID： PMC3146060          DOI： 10.1038/ki.2010.396

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  17 in total

1.  HET0016, a potent and selective inhibitor of 20-HETE synthesizing enzyme.

Authors:  N Miyata; K Taniguchi; T Seki; T Ishimoto; M Sato-Watanabe; Y Yasuda; M Doi; S Kametani; Y Tomishima; T Ueki; M Sato; K Kameo
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

2.  Inhibition of cytochrome P450omega-hydroxylase: a novel endogenous cardioprotective pathway.

Authors:  Kasem Nithipatikom; Eric R Gross; Michael P Endsley; Jeannine M Moore; Marilyn A Isbell; John R Falck; William B Campbell; Garrett J Gross
Journal:  Circ Res       Date:  2004-09-23       Impact factor: 17.367

3.  Prevention of kidney ischemia/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment.

Authors:  K M Park; A Chen; J V Bonventre
Journal:  J Biol Chem       Date:  2001-01-09       Impact factor: 5.157

Review 4.  The changing epidemiology of acute renal failure.

Authors:  Norbert Lameire; Wim Van Biesen; Raymond Vanholder
Journal:  Nat Clin Pract Nephrol       Date:  2006-07

5.  Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke.

Authors:  Noriyuki Miyata; Takayuki Seki; Yu Tanaka; Tomohiro Omura; Kazuo Taniguchi; Mariko Doi; Kagumi Bandou; Shunichi Kametani; Masakazu Sato; Shigeru Okuyama; Liana Cambj-Sapunar; David R Harder; Richard J Roman
Journal:  J Pharmacol Exp Ther       Date:  2005-04-14       Impact factor: 4.030

6.  Differential effects of 20-hydroxyeicosatetraenoic acid on intrarenal blood flow in the rat.

Authors:  Adebayo O Oyekan
Journal:  J Pharmacol Exp Ther       Date:  2005-03-15       Impact factor: 4.030

7.  Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles.

Authors:  J D Imig; A P Zou; D E Stec; D R Harder; J R Falck; R J Roman
Journal:  Am J Physiol       Date:  1996-01

8.  MAPK activation determines renal epithelial cell survival during oxidative injury.

Authors:  J F di Mari; R Davis; R L Safirstein
Journal:  Am J Physiol       Date:  1999-08

9.  20-HETE agonists and antagonists in the renal circulation.

Authors:  M Alonso-Galicia; J R Falck; K M Reddy; R J Roman
Journal:  Am J Physiol       Date:  1999-11

Review 10.  P-450 metabolites of arachidonic acid in the control of cardiovascular function.

Authors:  Richard J Roman
Journal:  Physiol Rev       Date:  2002-01       Impact factor: 37.312
View more
  9 in total

1.  Deficiency in the Formation of 20-Hydroxyeicosatetraenoic Acid Enhances Renal Ischemia-Reperfusion Injury.

Authors:  Yoshikazu Muroya; Fan Fan; Kevin R Regner; John R Falck; Michael R Garrett; Luis A Juncos; Richard J Roman
Journal:  J Am Soc Nephrol       Date:  2015-02-02       Impact factor: 10.121

Review 2.  Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.

Authors:  Fan Fan; Richard J Roman
Journal:  J Am Soc Nephrol       Date:  2017-07-12       Impact factor: 10.121

3.  A synthetic epoxyeicosatrienoic acid analogue prevents the initiation of ischemic acute kidney injury.

Authors:  Uwe Hoff; Gordana Bubalo; Mandy Fechner; Maximilian Blum; Ye Zhu; Andreas Pohlmann; Jan Hentschel; Karen Arakelyan; Erdmann Seeliger; Bert Flemming; Dennis Gürgen; Michael Rothe; Thoralf Niendorf; Vijaya L Manthati; John R Falck; Michael Haase; Wolf-Hagen Schunck; Duska Dragun
Journal:  Acta Physiol (Oxf)       Date:  2019-06-02       Impact factor: 6.311

Review 4.  Role of medullary blood flow in the pathogenesis of renal ischemia-reperfusion injury.

Authors:  Kevin R Regner; Richard J Roman
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

5.  Impaired myogenic response and autoregulation of cerebral blood flow is rescued in CYP4A1 transgenic Dahl salt-sensitive rat.

Authors:  Fan Fan; Aron M Geurts; Sydney R Murphy; Mallikarjuna R Pabbidi; Howard J Jacob; Richard J Roman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-12-24       Impact factor: 3.619

Review 6.  Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.

Authors:  Fan Fan; Ying Ge; Wenshan Lv; Matthew R Elliott; Yoshikazu Muroya; Takashi Hirata; George W Booz; Richard J Roman
Journal:  Front Biosci (Landmark Ed)       Date:  2016-06-01

Review 7.  Cytochrome P450 eicosanoids in hypertension and renal disease.

Authors:  Fan Fan; Yoshikazu Muroya; Richard J Roman
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-01       Impact factor: 2.894

8.  Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.

Authors:  Ye Zhu; Maximilian Blum; Uwe Hoff; Tim Wesser; Mandy Fechner; Christina Westphal; Dennis Gürgen; Rusan Ali Catar; Aurelie Philippe; Kaiyin Wu; Gordana Bubalo; Michael Rothe; Steven M Weldon; Duska Dragun; Wolf-Hagen Schunck
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

Review 9.  Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic Target.

Authors:  Osama H Elshenawy; Sherif M Shoieb; Anwar Mohamed; Ayman O S El-Kadi
Journal:  Pharmaceutics       Date:  2017-02-20       Impact factor: 6.321
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.